End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114,600 KRW | +0.44% | -0.95% | -8.69% |
05-03 | Green Cross Widens Q1 Loss, Sales Inch Up 2% | MT |
03-20 | GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on GC Biopharma Corp.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.38% | 2 M€ | -14.14% | ||
0.05% | 2 M€ | -.--% | ||
0.01% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +4.81% | - | |
0.00% | 0 M€ | +3.95% | - | |
0.00% | 0 M€ | +8.24% | - | |
0.00% | 0 M€ | +5.79% | - | |
0.00% | 0 M€ | +5.63% | - | |
0.00% | 0 M€ | +3.63% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.69% | 955M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- A006280 Stock
- Funds and ETFs GC Biopharma Corp.